English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

China’s Grandhope Biotech In-licenses Stem Cell Technology from Orthocell

Feb. 3, 2013

Guangzhou-based Grandhope Biotech has in-licensed the China rights to an autologous stem cell tendon-repair technology from the Australian firm Orthocell Limited. The technology harvests healthy tendon cells from the patient, cultures them, and then implants a mixture of the cells and a scaffolding matrix to the damaged tendon. Terms of the agreement were not disclosed.